NCT01491321

Brief Summary

The purpose of this study is to evaluate the efficacy of bee venom acupuncture on pain intensity, functional status and quality of life of patients with chronic low back pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Apr 2011

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 7, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 14, 2011

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
Last Updated

March 21, 2012

Status Verified

March 1, 2012

Enrollment Period

11 months

First QC Date

December 7, 2011

Last Update Submit

March 20, 2012

Conditions

Keywords

chronic low back painbee venom acupuncture

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale for bothersomeness

    Changes from baseline in VAS at 1 month

Secondary Outcomes (4)

  • Visual Analogue Scale for pain intensity

    Changes from baseline in VAS at 1 month

  • Disability scores on Oswestry Disability Index

    Changes from baseline in ODI at 1 month

  • Quality of Life scores on EQ-5D

    Changes from baseline in EQ-5D at 1 month

  • Depression scores on Beck Depression Inventory

    Changes from baseline in BDI at 1 month

Study Arms (2)

Bee Venom Acupuncture & Loxoprofen

EXPERIMENTAL
Procedure: Bee Venom Acupuncture TherapyDrug: Loxoprofen

Sham Bee Venom Acupuncture & Loxoprofen

PLACEBO COMPARATOR
Drug: LoxoprofenProcedure: Placebo

Interventions

Bee Venom 1:20,000 under BVA Increment Protocol Increment Protocol as * 1st week : SC 0.2cc/day, 2days/week * 2nd week : SC 0.4cc/day, 2days/week * 3rd week : SC 0.8cc/day, 2days/week

Also known as: pharmacopuncture
Bee Venom Acupuncture & Loxoprofen

60 mg/Tab, pers os 1Tab tid, for 3 weeks

Also known as: Loxonin
Bee Venom Acupuncture & LoxoprofenSham Bee Venom Acupuncture & Loxoprofen
PlaceboPROCEDURE

Normal Saline (0.9% NaCl) under NS Increment Protocol Increment Protocol as * 1st week : SC 0.2cc/day, 2days/week * 2nd week : SC 0.4cc/day, 2days/week * 3rd week : SC 0.8cc/day, 2days/week

Sham Bee Venom Acupuncture & Loxoprofen

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • nonspecific, chronic low back pain over 3 months
  • Must have LBP of more than VAS 4

You may not qualify if:

  • cancer, vertebral fracture, spinal infection, inflammatory spondylitis
  • spinal operation
  • radicular pain
  • other musculoskeletal pain
  • physicological or mental disorders
  • allergic history to BV therapy or insect bite

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spine Center, Kyung Hee University Hospital at Gangdong

Seoul, 134-727, South Korea

RECRUITING

Related Publications (1)

  • Seo BK, Lee JH, Sung WS, Song EM, Jo DJ. Bee venom acupuncture for the treatment of chronic low back pain: study protocol for a randomized, double-blinded, sham-controlled trial. Trials. 2013 Jan 14;14:16. doi: 10.1186/1745-6215-14-16.

MeSH Terms

Interventions

loxoprofen

Study Officials

  • Jun-Hwan Lee

    Spine Center, Kyung Hee University Hospital at Gangdong

    PRINCIPAL INVESTIGATOR
  • Byung-Kwan Seo

    Spine Center, Kyung Hee University Hospital at Gangdong

    STUDY DIRECTOR
  • Dae-Jin Cho

    Spine Center, Kyung Hee University Hospital at Gangdong

    STUDY DIRECTOR

Central Study Contacts

Byung-Kwan Seo

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

December 7, 2011

First Posted

December 14, 2011

Study Start

April 1, 2011

Primary Completion

March 1, 2012

Study Completion

March 1, 2012

Last Updated

March 21, 2012

Record last verified: 2012-03

Locations